Pfizer raises 2022 earnings guidance, beats third-quarter expectations
November 01, 2022 at 07:27 AM EDT
Pfizer now expects earnings per share of $6.40 to $6.50 for the year, up from its previous forecast of $6.30 to $6.45.
Photography by Christophe Tomatis